Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711805013 | Rotigotine-containing product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711806014 | Product containing rotigotine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rotigotine-containing product in transdermal dose form | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some | ||
| Rotigotine-containing product in transdermal dose form | est un(e) (attribut) | rotigotine | true | Inferred relationship | Some | ||
| Rotigotine-containing product in transdermal dose form | est un(e) (attribut) | Product manufactured as transdermal dose form (product) | true | Inferred relationship | Some | ||
| Rotigotine-containing product in transdermal dose form | a une forme pharmaceutique (attribut) | forme transdermique (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Rotigotine-containing product in transdermal dose form | a pour principe actif (attribut) | Rotigotine (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only rotigotine in transdermal dose form (medicinal product form) | est un(e) (attribut) | True | Rotigotine-containing product in transdermal dose form | Inferred relationship | Some | |
| Rotigotine 83.333 microgram/hour prolonged-release transdermal patch | est un(e) (attribut) | False | Rotigotine-containing product in transdermal dose form | Inferred relationship | Some | |
| Rotigotine 166.667 microgram/hour prolonged-release transdermal patch | est un(e) (attribut) | False | Rotigotine-containing product in transdermal dose form | Inferred relationship | Some | |
| Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) | est un(e) (attribut) | False | Rotigotine-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR